Application 050779
- Type
- NDA
- Sponsor
- B BRAUN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 002 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | Yes | Yes |
| 003 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | Yes | No |
| 004 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 3GM BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050779-001 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | ||
| N050779-002 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | |
| N050779-003 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | |
| N050779-004 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 3f0d92c62455… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | N050779-001 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-002 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-003 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-001 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-002 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-003 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-001 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-002 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-003 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-001 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-002 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-003 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-001 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-002 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-003 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-001 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-002 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-003 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-001 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-002 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-003 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-001 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-002 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-003 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-001 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-002 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-003 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-001 | NPP | 2023-11-23 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-002 | NPP | 2023-11-23 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-003 | NPP | 2023-11-23 | e64feba35796… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefazolin Sodium | CEFAZOLIN SODIUM | B. Braun Medical Inc. | 17f8f038-c204-4dab-80d7-6f7ac41ddbec | 2025-03-10 | Warnings, Adverse reactions | 050779 NDA050779 0264-3103 0264-3105 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80901 | SUPPL | 2025-02-04 |
| 79510 | SUPPL | 2024-09-02 |
| 79485 | SUPPL | 2024-08-27 |
| 68975 | SUPPL | 2021-10-13 |
| 68962 | SUPPL | 2021-10-12 |
| 65344 | SUPPL | 2020-11-25 |
| 65328 | SUPPL | 2020-11-25 |
| 64234 | SUPPL | 2020-08-07 |
| 39321 | SUPPL | 2015-10-15 |
| 30525 | SUPPL | 2015-10-13 |
| 30524 | SUPPL | 2014-09-23 |
| 30523 | SUPPL | 2012-04-25 |
| 39320 | SUPPL | 2012-04-23 |
| 18231 | SUPPL | 2012-01-26 |
| 30522 | SUPPL | 2012-01-18 |
| 8269 | SUPPL | 2008-11-07 |
| 42732 | SUPPL | 2007-09-24 |
| 39319 | SUPPL | 2007-09-11 |
| 8270 | SUPPL | 2007-09-11 |
| 30521 | SUPPL | 2005-05-17 |
| 39318 | SUPPL | 2004-07-01 |
| 8268 | SUPPL | 2004-07-01 |
| 22235 | ORIG | 2000-08-04 |
| 18230 | ORIG | 2000-08-04 |
| 8267 | ORIG | 2000-08-04 |